The FDA approved Itvisma gene therapy for patients aged 2 years and older with spinal muscular atrophy and confirmed SMN1 ...
Moving complex spine to ASCs saves 60%, but professionals warn that standard facilities aren't ready, as it takes ...
Milestone enables immediate production of SiN/PEEK custom devices SALT LAKE CITY, Utah, Dec. 01, 2025 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback